首页> 外文期刊>Disease models & mechanisms: DMM >The tumor suppressor gene Trp53 protects the mouse lens against posterior subcapsular cataracts and the BMP receptor Acvr1 acts as a tumor suppressor in the lens
【24h】

The tumor suppressor gene Trp53 protects the mouse lens against posterior subcapsular cataracts and the BMP receptor Acvr1 acts as a tumor suppressor in the lens

机译:抑癌基因Trp53保护小鼠晶状体免受后囊性白内障的侵害,BMP受体Acvr1在晶状体中起到抑癌作用

获取原文
           

摘要

We previously found that lenses lacking the Acvr1 gene, which encodes a bone morphogenetic protein (BMP) receptor, had abnormal proliferation and cell death in epithelial and cortical fiber cells. We tested whether the tumor suppressor protein p53 (encoded by Trp53 ) affected this phenotype. Acvr1 conditional knockout ( Acvr1CKO ) mouse fiber cells had increased numbers of nuclei that stained for p53 phosphorylated on serine 15, an indicator of p53 stabilization and activation. Deletion of Trp53 rescued the Acvr1CKO cell death phenotype in embryos and reduced Acvr1 -dependent apoptosis in postnatal lenses. However, deletion of Trp53 alone increased the number of fiber cells that failed to withdraw from the cell cycle. Trp53CKO and Acvr1;Trp53DCKO (double conditional knockout), but not Acvr1CKO , lenses developed abnormal collections of cells at the posterior of the lens that resembled posterior subcapsular cataracts. Cells from human posterior subcapsular cataracts had morphological and molecular characteristics similar to the cells at the posterior of mouse lenses lacking Trp53 . In Trp53CKO lenses, cells in the posterior plaques did not proliferate but, in Acvr1;Trp53DCKO lenses, many cells in the posterior plaques continued to proliferate, eventually forming vascularized tumor-like masses at the posterior of the lens. We conclude that p53 protects the lens against posterior subcapsular cataract formation by suppressing the proliferation of fiber cells and promoting the death of any fiber cells that enter the cell cycle. Acvr1 acts as a tumor suppressor in the lens. Enhancing p53 function in the lens could contribute to the prevention of steroid- and radiation-induced posterior subcapsular cataracts.
机译:我们先前发现缺少Acvr1基因(其编码骨形态发生蛋白(BMP)受体)的晶状体在上皮和皮层纤维细胞中具有异常增殖和细胞死亡。我们测试了肿瘤抑制蛋白p53(由Trp53编码)是否影响了该表型。 Acvr1条件性基因敲除(Acvr1CKO)小鼠纤维细胞的细胞核数目增加了,染色的丝氨酸15磷酸化了p53,这是p53稳定和激活的指标。 Trp53的删除挽救了胚胎中的Acvr1CKO细胞死亡表型,并减少了出生后晶状体中Acvr1依赖性的细胞凋亡。然而,仅删除Trp53增加了未能退出细胞周期的纤维细胞的数量。 Trp53CKO和Acvr1; Trp53DCKO(双重条件基因敲除),而不是Acvr1CKO,在晶状体后部形成了类似于后囊状白内障的异常细胞集合。来自人后囊内白内障的细胞的形态和分子特征与缺乏Trp53的小鼠晶状体后的细胞相似。在Trp53CKO晶状体中,后斑块中的细胞没有增殖,但是在Acvr1; Trp53DCKO晶状体中,后斑块中的许多细胞继续增殖,最终在晶状体后部形成血管化的肿瘤样肿块。我们得出结论,p53通过抑制纤维细胞的增殖并促进进入细胞周期的任何纤维细胞的死亡,来保护晶状体免受后囊后白内障形成。 Acvr1在晶状体中起着抑癌作用。增强晶状体中的p53功能可能有助于预防类固醇和放射线诱发的后囊状白内障。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号